top
Search terms
Results 1 - 6 of 6 - ordered by :
Ehjournal

[...]patients with renal insufficiency have a particularly high risk of coronary events, actually higher than that of most diabetic patients.2 Second, the interaction between renal failure and ...

European Heart Journal, Editorial, Nicolas Danchin, Etienne Puymirat, François Schiele

Date : 21/01/2016 Item size : 184766 bytes
Ehjournal

[...]patients with renal insufficiency have a particularly high risk of coronary events, actually higher than that of most diabetic patients.2 Second, the interaction between renal failure and ...

European Heart Journal, Danchin, Nicolas, Puymirat, Etienne, Schiele, François

Date : 21/01/2016
Escardio

Insights from a single center PCI registry Roxana MEHRAN (New York, United States of America) 08:30 P1511 Association of a reduced antiplatelet activity of CYP3A4-metabolized statin with clinical ...

Poster session 2: Miscellaneous

Date : 30/08/2015 Item size : 107075 bytes
Escardio

Stockholm, Sweden, 29 August: Antithrombotic therapy using antiplatelet and anticoagulant agents is the cornerstone of treatment for acute and chronic coronary artery disease (CAD), yet it is also ...

Date : 29/08/2010
Ehjournal

Dual antiplatelet therapy is the mainstay of antiplatelet treatment in percutaneous coronary interventions (PCIs) with stent implantation, as well as in acute coronary syndromes (ACS) with and ...

European Heart Journal, Schiele, Francois, Meneveau, Nicolas, Bassand, Jean-Pierre

Date : 01/06/2008
Ehjournal

Dual antiplatelet therapy is the mainstay of antiplatelet treatment in percutaneous coronary interventions (PCIs) with stent implantation, as well as in acute coronary syndromes (ACS) with and ...

European Heart Journal, Schiele, Francois, Meneveau, Nicolas, Bassand, Jean-Pierre

Date : 01/06/2008 Item size : 171577 bytes